Time-resolved laser-induced fluorescence spectroscopy systems and uses thereof

Patent metadata

Field	Value
Publication number	US-10288567-B2
Application number	US-201615196354-A
Country	US
Kind code	B2
Filing date	Jun 29, 2016
Priority date	Mar 15, 2013
Publication date	May 14, 2019
Grant date	May 14, 2019

Abstract

The invention provides systems for characterizing a biological sample by analyzing emission of fluorescent light from the biological sample upon excitation and methods for using the same. The system includes a laser source, collection fibers, a demultiplexer and an optical delay device. All references cited herein are incorporated by reference in their entirety as though fully set forth. Unless defined otherwise, technical and scientific tens used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.

First claim

The invention claimed is:

1. A system for characterizing a biological sample by analyzing emission of fluorescent light from the biological sample upon excitation comprising:
(a) a laser source connected to a biological sample via excitation fibers (ExF), wherein the laser source is configured to irradiate the biological sample with a laser pulse at a predetermined wavelength to cause the biological sample to produce a responsive fluorescence signal;
(b) collection fibers (CF), wherein the CF collect the responsive fluorescence signal from the biological sample, and relay the responsive fluorescence signal to a demultiplexer;
(c) the demultiplexer configured to split the responsive fluorescence signal from the CF at pre-determined wavelengths to obtain spectral bands,
wherein the demultiplexer comprises a plurality of wavelength splitting devices each being configured to split light at a pre-determined wavelength,
wherein the plurality of wavelength splitting devices comprises at least three wavelength splitting devices,
wherein a first wavelength splitting device is configured to split the responsive fluorescence signal into a first signal and a second signal,
wherein a second wavelength splitting device is configured to split the second signal into a third signal and a fourth signal, and
wherein a third wavelength splitting device is configured to:
(i) split the first signal into a fifth signal and a sixth signal,
(ii) split the fourth signal into a fifth signal and a sixth signal, wherein the first signal comprises wavelengths which are less than wavelengths of the second signal, and wherein the third signal comprises wavelengths which are greater than wavelengths of the fifth signal and wavelengths of the sixth signal, or
(iii) split the fourth signal into a fifth signal and a sixth signal, wherein the first signal comprises wavelengths which are more than wavelengths of the second signal, and wherein the third signal comprises wavelengths which are less than wavelengths of the fourth signal; and

(d) an optical delay device.

2. The system of claim 1 , wherein the optical delay device is adapted to couple the spectral bands from the demultiplexer into the optical delay device, allow the spectral bands to travel through the optical delay device, and introduce a controlled time delay to the spectral bands as the spectral bands travel through optical delay device, so as to capture multiple wavelengths in a single shot.

3. The system of claim 1 , wherein the collection fibers (CF) form a single bundle.

4. A method for characterizing a biological sample by analyzing emission of a fluorescence signal from the biological sample upon excitation comprising:
(a) irradiating the biological sample with a laser pulse at a predetermined wavelength to cause the biological sample to produce a responsive fluorescence signal;
(b) collecting the responsive fluorescence signal from the biological sample;
(c) splitting the responsive fluorescence signal with a demultiplexer at predetermined wavelengths to obtain spectral bands,
wherein the demultiplexer comprises a plurality of wavelength splitting devices each being configured to split light at a pre-determined wavelength,
wherein the plurality of wavelength splitting devices comprises at least three wavelength splitting devices,
wherein the responsive fluorescence signal is split into a first signal and a second signal by a first wavelength splitting device,
wherein the second signal is split into a third signal and a fourth signal by a second wavelength splitting device, and
wherein a third wavelength splitting device:
(i) splits the first signal into a fifth signal and a sixth signal,
(ii) splits the fourth signal into a fifth signal and a sixth signal, wherein the first signal comprises wavelengths which are less than wavelengths of the second signal, and wherein the third signal comprises wavelengths which are greater than wavelengths of the fifth signal and wavelengths of the sixth signal, or
(iii) splits the fourth signal into a fifth signal and a sixth signal, wherein the first signal comprises wavelengths which are more than wavelengths of the second signal, and wherein the third signal comprises wavelengths which are less than wavelengths of the fourth signal; and

(d) passing the spectral bands through a time-delay mechanism;
(e) obtaining the time-delayed spectral bands; and
(f) processing the time-delayed spectral bands.

5. The method of claim 4 , wherein the responsive fluorescence signal is emitted by a biomolecule.

6. The method of claim 5 , wherein the biomolecule is any one or more of PLP-GAD (pyridoxal-5′-phosphate (PLP) glutamic acid decarboxylase (GAD)), bound NADH, free NADH, flavin mononucleotide (FMN) riboflavin, flavin adenine dinucleotide (FAD) riboflavin, lipopigments, endogenous porphyrins or a combination thereof.

7. A method for determining tissue viability comprising analyzing emission of fluorescence signals from biomolecules in the tissue by the method of claim 4 , wherein an increase in fluorescence of the biomolecules in the biological sample relative to a normal subject is indicative of poor tissue viability.

8. A method for continuously monitoring cellular metabolism comprising analyzing emission of a fluorescence signal by the method of claim 4 .

9. A method for determining drug or metabolite level in plasma comprising analyzing emission of a fluorescence signal from a biomolecule by the method of claim 4 .

10. The method of claim 9 , wherein the biomolecule is NADH.

11. The method of claim 10 , wherein NADH is in free form, bound form or a combination thereof.

12. The system of claim 1 , further comprising a photomultiplier tube configured to detect the spectral bands received from the optical delay device.

13. The system of claim 12 , further comprising a digitizer configured to digitize the spectral bands received from the photomultiplier tube.

14. The system of claim 13 , further comprising a preamplifier configured to amplify the spectral bands received from the photomultiplier tube before the spectral bands are digitized by the digitizer.

15. The system of claim 13 , further comprising a computer system configured to process and display the spectral bands received from the digitizer.

16. The method of claim 4 , wherein processing the time-delayed spectral bands comprises detecting the time-delayed spectral bands.

17. The method of claim 16 , further comprising digitizing the detected time-delayed spectral bands.

18. The method of claim 16 , further comprising amplifying the detected time-delayed spectral bands prior to digitizing the detected time-delayed spectral bands.

19. The method of claim 16 , further comprising processing and displaying the digitized time-delayed spectral bands with a computer system.

20. The system of claim 1 , wherein the third wavelength splitting device is configured to split the fourth signal into the fifth signal and the sixth signal, wherein the first signal comprises wavelengths which are less than wavelengths of the second signal, and wherein the third signal comprises wavelengths which are greater than wavelengths of the fifth signal and wavelengths of the sixth signal.

21. The system of claim 20 , wherein a first spectral band comprises the first signal, a second spectral band comprises the third signal, a third spectral band comprises the fifth signal, and a fourth spectral band comprises the sixth signal.

22. The system of claim 21 ,

Assignees

• Cedars Sinai Medical Center

Inventors

• Butte Pramod
• Lapchak Paul
• Kittle David Scott

Classifications

• G01N2021/6484

  Optical fibres · CPC title

• G01N21/6486 Primary

  Measuring fluorescence of biological material, e.g. DNA, RNA, cells (G01N21/6428 takes precedence) · CPC title

• A61B5/4866

  Evaluating metabolism (using breath test A61B5/083) · CPC title

• A61B5/1459

  invasive, e.g. introduced into the body by a catheter · CPC title

• G01N21/6428

  Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53) · CPC title